Cargando…
Hemoclot Thrombin Inhibitor Assay and Expected Peak-Trough Levels of Dabigatran: A Multicenter Study
PURPOSE: Dabigatran concentrations monitoring are gaining importance of special situations, but limited data are available for the expected peak and trough levels. The hemoclot thrombin inhibitor (HTI) is dabigatran-calibrated quantitative determination of dabigatran concentration. This study aims t...
Autores principales: | Liu, Zhiyan, Mu, Guangyan, Xie, Qiufen, Zhang, Hanxu, Jiang, Jie, Xiang, Qian, Cui, Yimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353555/ https://www.ncbi.nlm.nih.gov/pubmed/35935625 http://dx.doi.org/10.3389/fcvm.2022.894888 |
Ejemplares similares
-
SLC4A4, FRAS1, and SULT1A1 Genetic Variations Associated With Dabigatran Metabolism in a Healthy Chinese Population
por: Xie, Qiufen, et al.
Publicado: (2022) -
Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa®)
Publicado: (2010) -
Genetic variations in relation to bleeding and pharmacodynamics of dabigatran in Chinese patients with nonvalvular atrial fibrillation: A nationwide multicentre prospective cohort study
por: Xiang, Qian, et al.
Publicado: (2022) -
Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report
por: Xiang, Qian, et al.
Publicado: (2020) -
Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population
por: Zhang, Fan, et al.
Publicado: (2022)